Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis
Osteoarthritis (OA) is a common degenerative disease characterized by the destruction of articular cartilage and chronic inflammation of surrounding tissues. Matrix metalloproteinase-13 (MMP-13) is the primary MMP involved in cartilage degradation through its particular ability to cleave type II col...
Main Authors: | Qichan Hu, Melanie Ecker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/4/1742 |
Similar Items
-
Trabecular Bone Parameters, TIMP-2, MMP-8, MMP-13, VEGF Expression and Immunolocalization in Bone and Cartilage in Newborn Offspring Prenatally Exposed to Fumonisins
by: Ewa Tomaszewska, et al.
Published: (2021-11-01) -
New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis
by: Heng Li, et al.
Published: (2017-11-01) -
Evaluation of the Effect of Phytocomplex on Chondroprotective Biomarkers in an Experimental Model of Osteoarthritis in Rats
by: Shridhar PANDYA, et al.
Published: (2022-12-01) -
Repair Effects of Xiaoyusan New Formula on Cartilage Injury and MMP-13 Expression in Knee Osteoarthritis Model Rabbits
by: CUI Ruolin, et al.
Published: (2023-02-01) -
MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis
by: Qiumei Lan, et al.
Published: (2020-08-01)